文献速递外周动脉疾病

GLASS P2修饰者腔内治疗结局:识别真无选项解剖模式

Endovascular therapy outcomes in patients with the Global Limb Anatomical Staging System P2 modifier to identify the true no-option anatomic pattern in chronic limb-threatening ischemia.
PubMed 文献 · J Vasc Surg · 2025-07-16

本研究多中心回顾性分析151例患者160条肢体,均因慢性肢体威胁性缺血(CLTI)伴GLASS P2修饰者接受腔内治疗(EVT)。2年无截肢生存率57.8%、保肢率75.1%、创面愈合率60.1%。严重足部内侧动脉钙化(pMAC)合并靶区踝下血管流出缺失独立预测手术失败,且手术失败显著恶化临床结局。

要点

  • GLASS P2修饰者EVT术后2年无截肢生存率57.8%、保肢率75.1%、创面愈合率60.1%。
  • 严重pMAC合并踝下靶血管流出缺失者手术失败率高达85.4%,应视为真无选项解剖。
  • 此类高危患者EVT可能恶化结局,深静脉动脉化可作为替代方案。

核心结论

  • CLTI伴GLASS P2修饰者中,严重pMAC合并靶区踝下血管流出缺失提示真无选项解剖模式及并发症风险升高。
  • 此类高危病例EVT可能恶化而非改善结局,远端旁路不可行时应考虑深静脉动脉化等替代方法。

研究设计与样本

  • 多中心、回顾性、非随机观察性研究,日本北海道三家心血管科开展。
  • 共分析151例患者160条肢体,平均年龄73.4±10.9岁。

主要发现

  • 2年估计无截肢生存率57.8%、保肢率75.1%、创面愈合率60.1%。
  • 多因素logistic回归显示pMAC严重程度(轻/中/重)和靶区踝下血管流出缺失为手术失败独立预测因素。
  • 严重pMAC合并靶区踝下血管流出缺失时,41例中35例(85.4%)手术失败,41例中9例(22.0%)出现膝下血流恶化。
  • 手术成功组与失败组24个月无截肢生存率分别为68.4%与41.1%(log-rank P<.001),保肢率86.5%与56.1%(P<.001),创面愈合率70.0%与43.1%(P=.001)。

关键数值与推荐

  • 手术成功定义为至少一条足背动脉、外侧跖动脉或内侧跖动脉再通且血流直达创面。
  • 未达到上述结局定义为手术失败。

临床怎么用

  • 对GLASS P2修饰者行EVT前应评估pMAC严重程度及靶区踝下血管流出情况。
  • 严重pMAC合并靶区踝下血管流出缺失者,EVT失败风险极高且可能恶化膝下血流,应优先考虑替代方案。
  • 远端旁路不可行时,深静脉动脉化可作为此类真无选项解剖患者的治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In patients with chronic limb-threatening ischemia (CLTI), the Global Limb Anatomical Staging System (GLASS) P2 modifier, defined by the absence of a target artery crossing the ankle and lack of a suitable pedal or plantar artery, indicates a no-option anatomic pattern. Although several studies have reported successful endovascular therapy (EVT) in such patients, EVT outcome predictors in this high-risk population remain unclear. This study aimed to identify factors contributing to procedural failure in patients with the GLASS P2 modifier undergoing EVT. It also evaluated the impact of inframalleolar angioplasty on clinical outcomes in patients with CLTI and the GLASS P2 modifier. METHODS: This multicenter, retrospective, nonrandomized observational study was conducted at three cardiovascular departments in Hokkaido, Japan. Patients aged ≥20 years with CLTI (Rutherford classification 4-6) who underwent EVT for de novo inframalleolar occlusions with the GLASS P2 modifier during January 2016 to December 2023 were enrolled. RESULTS: In total, 160 limbs in 151 patients (mean age, 73.4 ± 10.9 years) were analyzed. At 2 years, the estimated amputation-free survival, limb salvage, and wound healing rates were 57.8%, 75.1%, and 60.1%, respectively. Procedural success was defined as recanalization of at least one dorsalis pedis, lateral plantar, or medial plantar artery with inline flow to the wound. Failure to meet this outcome was classified as procedural failure. Multivariate logistic regression identified pedal medial arterial calcification (pMAC) severity (mild/moderate/severe) and the absence of target inframalleolar vessel outflow as independent predictors of procedural failure. Notably, when severe pMAC coexisted with absent target inframalleolar vessel outflow, procedural failure occurred in 35 of 41 cases (85.4%), with infrapopliteal blood flow deterioration observed in nine of 41 cases (22.0%). Procedural failure significantly impacted clinical outcomes. In the successful vs failed IMA groups, 24-month amputation-free survival was 68.4% vs 41.1% (log-rank P < .001), limb salvage was 86.5% vs 56.1% (log-rank P < .001), and wound healing was 70.0% vs 43.1% (log-rank P = .001), respectively. CONCLUSIONS: Among patients with CLTI and the GLASS P2 modifier, the combination of severe pMAC and absent target inframalleolar vessel outflow indicates a true no-option anatomic pattern as well as elevated complication risk. In such high-risk cases, EVT may worsen outcomes rather than improve them. Therefore, alternative approaches such as deep venous arterialization should be considered when distal bypass is not an option.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Iwata S, Mizuguchi Y, Suzuki R, et al. Endovascular therapy outcomes in patients with the Global Limb Anatomical Staging System P2 modifier to identify the true no-option anatomic pattern in chronic limb-threatening ischemia. J Vasc Surg. 2025. PMID: 40680900. doi:10.1016/j.jvs.2025.07.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。